NCT06537869 iCBT for Seniors With Depression in Primary Care
| NCT ID | NCT06537869 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Göteborg University |
| Condition | Depression Mild |
| Study Type | INTERVENTIONAL |
| Enrollment | 390 participants |
| Start Date | 2024-09-01 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 390 participants in total. It began in 2024-09-01 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial aims to evaluate the potential benefits of internet cognitive behavioural therapy (iCBT) for elderly patients with mild/moderate depression and compare its effectiveness with the current treatment as usual (TAU) at primary care centres (PCCs). The specific aims are to study if: iCBT is as effective as TAU in reducing depressive symptoms iCBT is as effective as TAU in increasing quality of life iCBT is as effective as TAU in increasing the function in patients \>65 years and older with mild/moderate depression attending primary care, with the perspective of 36 months. Participants will: Work with the iCBT program (10-12 weeks) or become TAU at their PCCs. Followed-up at 3, 6, 12, 24 and 36 months of their symptoms, quality of life and function.
Eligibility Criteria
Inclusion Criteria: * All patients \>65, attending PCCs engaged in the trial, with mood as well as somatic complaints will be asked about depressive symptoms during the last 2 weeks by NICE guidelines for depression. * All patients diagnosed with minor/major depression and not belonging to exclusion criteria and willing to take part in the trial will be diagnosed via the Mini International Neuropsychiatric Interview (M.I.N.I.) by a psychologist/specially trained nurse and have a General Practitioner (GP) somatic consultation Exclusion Criteria: Patients diagnosed with: * severe depression * prior suicide attempt or currently at medium to high risk of suicide (MADRS-S question 9\>3 points or MINI suicide \>9) * bipolar disorder * psychosis * addiction * cognitive impairment * not speaking or understanding Swedish.
Contact & Investigator
Dominique Hange, Ass Prof
PRINCIPAL INVESTIGATOR
Göteborg University
Frequently Asked Questions
Who can join the NCT06537869 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Depression Mild. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06537869 currently recruiting?
Yes, NCT06537869 is actively recruiting participants. Contact the research team at dominique.hange@allmed.gu.se for enrollment information.
Where is the NCT06537869 trial being conducted?
This trial is being conducted at Gothenburg, Sweden.
Who is sponsoring the NCT06537869 clinical trial?
NCT06537869 is sponsored by Göteborg University. The principal investigator is Dominique Hange, Ass Prof at Göteborg University. The trial plans to enroll 390 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.